Lung Disease and Infection | Page 2 | European Cystic Fibrosis Society (ECFS)

Association of Inhaled Antibiotics in Addition to Standard Intravenous Therapy and Outcomes of Pediatric Inpatient Pulmonary Exacerbations

Predicting Risk-Adjusted Incidence Rates of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in the Cystic Fibrosis Programs in the United States

Use of the CFTR modulator combination elexacaftor/tezacaftor/ivacaftor after lung transplant

How does early eradication of Pseudomonas affect lung function?

Breakdown of lung proteins causes structural damage in cystic fibrosis lungs

Respiratory viral infections and chest CT (computer tomography scan) changes in infants with CF

High blood eosinophil counts are linked with worse symptoms in adults with cystic fibrosis

Club cell secretory protein is reduced in children with cystic fibrosis who have severe lung disease

Using inhaled aztreonam in the treatment of exacerbations of cystic fibrosis

Inflammation and infection change what mucus is made of, how much gets made, and how much it can dissolve

first
previous
1
2
3
4
5
6
7
next
last